Company Research Report: Oculus Pathology
Company Overview
- Name: Oculus Pathology
- Mission of the Company: Oculus Pathology is committed to enhancing patient care through service, quality, and integrity.
- Founded: The origins trace back to its predecessor, Clinical Pathology Associates, which started in 1948.
- Founder: No information is available.
- Key People:
- Edward G. Weir, M.D.: Hematopathology
- Jennifer R. Rushton, M.D.: Hematopathology, Molecular Pathology
- Craig J. Peterson, M.D.: Gastrointestinal Pathology, Head & Neck Pathology
- Suzanne Ledet, M.D.: Cytopathology, Head & Neck Pathology, Placental Pathology
- Chandra Krishnan, M.D.: Hematopathology, Pediatric Pathology, Placental Pathology
- Megan Kressin, M.D.: Hematopathology
- Headquarters: 3445 Executive Center Drive, Suite 250, Austin, TX 78731
- Number of Employees: More than 45 board-certified pathologists
- Revenue of the Company: No information is available.
- Company Known For: Providing leading-edge anatomic and clinical pathology services to hospitals, ambulatory surgery centers, and physician practices.
Products and Services
Products Offered
- Specialty and Sub-specialty Pathology Services
- Breast Pathology
- Cytopathology
- Dermatopathology
- GI Pathology
- Gynecologic Pathology
- Head & Neck Pathology
- Hematopathology
- Molecular Pathology
- Neuropathology
- Pediatric Pathology
- Renal Pathology
- Surgical Pathology
- Transfusion Medicine
- Urologic Pathology
High-Level Description and Key Features
- Pathology Lab: CLIA-certified, physician-owned and -operated laboratory providing state-of-the-art testing with a focus on personalized care.
- Digital Pathology Services: Capable of processing large batches of samples rapidly, featuring collaboration through remote consultation and integration with EMRs for efficient diagnoses.
- Hospital Solutions: Offers a robust network of specialty pathologists ensuring seamless integration with hospital operations.
- Outpatient Solutions: Provides high standards of lab testing through a CLIA-certified laboratory.
- Advanced Surgery Centers: In-house sample processing with results delivered in as little as 48 hours.
Recent Developments
Recent Developments in the Company
- Rebranding: Clinical Pathology Associates has rebranded to Oculus Pathology to modernize its identity and enhance brand clarity.
- Enhanced Identity: The new brand identity highlights a commitment to staying ahead in the industry through innovation and modernization.
- Leadership Vision: Renewed commitment to the mission of exceptional care led by Matt Thompson, CEO.
New Products Launched
- Digital Pathology Enhancements: Emphasizes collaboration and remote consultations powered by the latest digital tools.
New Features Added to Existing Products
- Integrated EMR Systems: Improved efficiency in order entry and results retrieval.
- Operational Efficiencies: Streamlined workflows delivering faster and more accurate diagnoses.
New Partnerships
- Collaboration with Health Systems: Continues partnerships with major health networks like Tenet, Ascension, and HCA Healthcare, among others.
This concludes the research report on Oculus Pathology, providing insight into its robust service offerings, strategic rebranding, and ongoing commitment to healthcare excellence.
